[go: up one dir, main page]

PL2021794T3 - Zastosowanie białka S100A 12 jako markera raka okrężnicy i odbytnicy - Google Patents

Zastosowanie białka S100A 12 jako markera raka okrężnicy i odbytnicy

Info

Publication number
PL2021794T3
PL2021794T3 PL07725293T PL07725293T PL2021794T3 PL 2021794 T3 PL2021794 T3 PL 2021794T3 PL 07725293 T PL07725293 T PL 07725293T PL 07725293 T PL07725293 T PL 07725293T PL 2021794 T3 PL2021794 T3 PL 2021794T3
Authority
PL
Poland
Prior art keywords
colorectal cancer
protein
marker
diagnosis
relates
Prior art date
Application number
PL07725293T
Other languages
English (en)
Inventor
Norbert Wild
Herbert Andres
Ursula Garczarek
Andrea Geistanger
Marie-Luise Hagmann
Johann Karl
Friedemann Krause
Michael Pfeffer
Wolfgang Rollinger
Michael Tacke
Michael Thierolf
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PL2021794T3 publication Critical patent/PL2021794T3/pl

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57419Specifically defined cancers of colon
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/4727Calcium binding proteins, e.g. calmodulin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/795Porphyrin- or corrin-ring-containing peptides
    • G01N2333/805Haemoglobins; Myoglobins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81Protease inhibitors
    • G01N2333/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/8146Metalloprotease (E.C. 3.4.24) inhibitors, e.g. tissue inhibitor of metallo proteinase, TIMP
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/91Transferases (2.)
    • G01N2333/912Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • G01N2333/91205Phosphotransferases in general
    • G01N2333/9121Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL07725293T 2006-05-19 2007-05-16 Zastosowanie białka S100A 12 jako markera raka okrężnicy i odbytnicy PL2021794T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06010439 2006-05-19
EP07725293A EP2021794B8 (en) 2006-05-19 2007-05-16 Use of protein s100a 12 as a marker for colorectal cancer
PCT/EP2007/004378 WO2007134779A1 (en) 2006-05-19 2007-05-16 Use of protein s100a 12 as a marker for colorectal cancer

Publications (1)

Publication Number Publication Date
PL2021794T3 true PL2021794T3 (pl) 2010-12-31

Family

ID=37087565

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07725293T PL2021794T3 (pl) 2006-05-19 2007-05-16 Zastosowanie białka S100A 12 jako markera raka okrężnicy i odbytnicy

Country Status (15)

Country Link
US (3) US20090286328A1 (pl)
EP (1) EP2021794B8 (pl)
JP (1) JP4942813B2 (pl)
KR (1) KR101147586B1 (pl)
CN (1) CN101449163B (pl)
AT (1) ATE471512T1 (pl)
AU (1) AU2007251933B2 (pl)
BR (1) BRPI0711763A2 (pl)
CA (1) CA2651709A1 (pl)
DE (1) DE602007007209D1 (pl)
DK (1) DK2021794T3 (pl)
ES (1) ES2347485T3 (pl)
MX (1) MX2008014482A (pl)
PL (1) PL2021794T3 (pl)
WO (1) WO2007134779A1 (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10957217B2 (en) 2006-08-25 2021-03-23 Ronald A. Weitzman Population-sample regression in the estimation of population proportions
US11151895B2 (en) * 2006-08-25 2021-10-19 Ronald Weitzman Population-sample regression in the estimation of population proportions
ATE521894T1 (de) * 2007-11-20 2011-09-15 Hoffmann La Roche Verfahren zur beurteilung von kolorektalem krebs anhand einer stuhlprobe durch verwendung einer marker-kombination aus calprotectin und einem hämoglobin/haptoglobin-komplex
CN101932338A (zh) * 2008-01-31 2010-12-29 学校法人庆应义墪 抗癌剂感受性的判定方法
WO2009102788A2 (en) 2008-02-15 2009-08-20 Mayo Foundation For Medical Education And Research Detecting neoplasm
WO2015067913A1 (en) 2013-11-07 2015-05-14 Diagnodus Limited Biomarkers
CN103033623A (zh) * 2012-12-10 2013-04-10 天津市协和医药科技集团有限公司 人m2型丙酮酸激酶化学发光免疫分析试剂盒及制备方法
EP3000897B1 (en) * 2013-05-21 2019-10-16 Biomérieux Colorectal cancer prognosis agent kit
US10184154B2 (en) 2014-09-26 2019-01-22 Mayo Foundation For Medical Education And Research Detecting cholangiocarcinoma
CN107532124B (zh) 2015-03-27 2022-08-09 精密科学公司 检测食管疾病
CN107271681A (zh) * 2017-06-05 2017-10-20 中国人民解放军沈阳军区总医院 血浆s100a12在st段抬高型心肌梗死早期诊断中的应用
AU2019252672B2 (en) * 2018-04-12 2025-08-14 Board Of Regents, The University Of Texas System Biomarker for detecting cancer
EP4004549A1 (en) * 2019-07-23 2022-06-01 Stichting Het Nederlands Kanker Instituut- Antoni van Leeuwenhoek Ziekenhuis Progression markers for colorectal adenomas
EP4045913A4 (en) * 2019-10-18 2023-11-08 Exact Sciences Corporation Stool ANTIGEN TEST WITH MULTIPLE ANALYTES

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61137064A (ja) * 1984-12-07 1986-06-24 Fujirebio Inc 大腸癌の予備スクリ−ニング方法
DE3838900A1 (de) * 1988-11-17 1990-05-23 Scheefers Borchel Ursula Pyruvatkinase-isoenzym typ m2 (tumor m2-pk) spezifische antikoerper/verfahren zu deren herstellung und deren verwendung
JPH02193071A (ja) * 1989-01-20 1990-07-30 Green Cross Corp:The ハプトグロビン―ヘモグロビン複合体測定用試薬キット及びそれを用いるハプトグロビン―ヘモグロビン複合体の測定法
JPH08238090A (ja) * 1995-03-06 1996-09-17 Jiro Hitomi 新規カルシウム結合タンパク
US20030175713A1 (en) * 2002-02-15 2003-09-18 Clemens Sorg Method for diagnosis of inflammatory diseases using CALGRANULIN C
JP2004198419A (ja) * 2002-12-13 2004-07-15 Bayer Healthcare Llc Timp1を用いた検出方法
EP1601969A2 (en) * 2003-03-08 2005-12-07 Auvation Ltd Markers for colorectal cancer
US20050287544A1 (en) * 2003-12-01 2005-12-29 Francois Bertucci Gene expression profiling of colon cancer with DNA arrays
NZ553386A (en) * 2004-07-23 2010-05-28 Aspenbio Pharma Inc Methods and devices for diagnosis of appendicitis

Also Published As

Publication number Publication date
AU2007251933B2 (en) 2011-05-12
JP4942813B2 (ja) 2012-05-30
US20150192587A1 (en) 2015-07-09
BRPI0711763A2 (pt) 2011-12-06
ES2347485T3 (es) 2010-10-29
ATE471512T1 (de) 2010-07-15
CA2651709A1 (en) 2007-11-29
EP2021794A1 (en) 2009-02-11
DK2021794T3 (da) 2010-10-11
CN101449163A (zh) 2009-06-03
MX2008014482A (es) 2008-11-27
US20170115294A1 (en) 2017-04-27
DE602007007209D1 (de) 2010-07-29
EP2021794B8 (en) 2010-08-18
EP2021794B1 (en) 2010-06-16
HK1133295A1 (en) 2010-03-19
WO2007134779A1 (en) 2007-11-29
KR20090007454A (ko) 2009-01-16
JP2009537798A (ja) 2009-10-29
US20090286328A1 (en) 2009-11-19
AU2007251933A1 (en) 2007-11-29
KR101147586B1 (ko) 2012-08-23
CN101449163B (zh) 2014-06-25

Similar Documents

Publication Publication Date Title
PL2021794T3 (pl) Zastosowanie białka S100A 12 jako markera raka okrężnicy i odbytnicy
SG10201408392PA (en) Methods of determining patient response by measurement of her-3
ATE554389T1 (de) Apex als marker für lungenkrebs
EP2321430B8 (en) Method of evaluating oral cancer risk in human
KR100711046B1 (ko) 대장암에 대한 마커로서의 니코틴아미드n―메틸트랜스퍼라아제의 용도
MX2010005893A (es) Marcadores de expresion genica para enfermedad inflamatoria de intestino.
PH12018550037A1 (en) Quencher containing water-soluble polymer-conjugated nanomaterial and use thereof
EP2584049A3 (en) Gene expression markers for Crohn's disease
EP2075341A4 (en) METHOD FOR THE INVESTIGATION, DETERMINATION OR EVALUATION BY MEANS OF GENE EXPRESSION ANALYSIS
WO2005124356A3 (en) Use of protein cbp2 as a marker for colorectal cancer
WO2008153543A3 (en) Fluorescent mouse model
WO2008131261A3 (en) Peptide biomarkers of cardiovascular disease
ATE468535T1 (de) Verwendung von nnmt als marker für lungenkrebs
ATE503846T1 (de) Verfahren zur diagnose eines ovarialkarzinoms
WO2010000467A8 (en) Asc as a marker for lung cancer
WO2005040806A3 (en) Use of protein asc as a marker for breast cancer
ATE412182T1 (de) Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome
MX341181B (es) Metodo para someter a prueba a un sujeto que se cree esta predispuesto a tener cancer metastasico usando delta133p53beta.
WO2008090177A3 (en) Diagnosis of prostate cancer
DE602004001994D1 (de) Verwendung des proteins masp als marker für kolorektale karzinome
WO2009019366A3 (fr) Procede de dosage de l'aminoacylase 1 pour le diagnostic in vitro du cancer colorectal
WO2013165969A3 (en) Methods and kits for diagnosing heparin-induced thrombocytopenia
DE602005013430D1 (de) Verwendung von asc als marker für kolorektalkarzinome
WO2004071267A3 (en) Diagnosis of colorectal cancer by detection of nicotinamide n-methyltransferase in a stool sample
ATE393393T1 (de) Verwendung des proteins spee als marker für brustkrebs